Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2025-12-25 @ 9:41 PM
Study NCT ID:
NCT04985851
Status:
UNKNOWN
Last Update Posted:
2023-12-01
First Post:
2021-06-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Sponsor:
Shanghai Chest Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-07
First Submit QC Date:
None
Study First Post Date:
2021-08-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-28
Last Update Post Date:
2023-12-01
Last Update Post Date Type:
ACTUAL